T cell
Central nervous system cancer metastases – the evolution of diagnostics and treatment
August 4, 2025CERo therapeutics, Cancer, T cell, immunotherapy
The current forms of immunotherapy, how T cell therapy works and what the future holds
T-cell therapy – the evolution of cancer treatments
July 7, 2025CERo therapeutics, Cancer, T cell, immunotherapy
The current forms of immunotherapy, how T cell therapy works and what the future holds
Cardiff University team discovers new method of killing cancers
January 21, 2020Manufacturing and Production Cancer, Cancer cures, Cancerous, Cardiff University, T cell, cells, immune system, immunity, t-cell
A team at Cardiff University have discovered a new part of the human immune system that could be harnessed to …
T cells found to ‘acquire knowledge’ to take fight to metastatic cancer
May 17, 2017Research and Development Cancer, T cell, immunotherapy
T cells are widely known as being crucial in the fight against cancer within the body but little was known, …
Bad news for Adaptimmune as partial clinical hold placed on T-cell oncology trial
August 4, 2016Research and Development Adaptimmune, T cell, oncology, t-cell
Adaptimmune Therapeutics has received notice from the US Food and Drug Administration (FDA) that a partial clinical hold has been …
Targeted cancer therapies can suppress T cell immune responses, study finds
March 23, 2016Research and Development T cell, anti-cancer drugs, immunosuppresive, superagonist, wistar institute
Researchers at the Wistar Institute have developed a new method whereby targeted cancer therapies can provide appropriate therapeutics without supressing …
Merck Serono in $826m immuno-oncology deal
March 31, 2015Research and Development, Sales and Marketing Intrexon, Merck, Merck Serono, T cell, biopharma, cart, immuno-oncology, t-cell
Merck Serono has announced a significant deal with Intrexon to develop and bring new cancer treatments to market. The German …
UK makes £30m investment in T-Cell cancer therapy
January 22, 2015Research and Development, Sales and Marketing Autolus, Cancer, London, T cell, UK, government, oncology, syncona
The UK is making a £30 million R&D investment into a promising new type of cancer treatment and is to …
Adaptimmune wins fund payout
March 26, 2014Research and Development, Sales and Marketing Adaptimmune, Cancer, T cell, biomedical, noble, sme
Biotech firm Adaptimmune has been awarded £2.1 million from the UK government’s Biomedical Catalyst Fund, which was set up to …
Tolerx to collaborate on first-in-class cancer antibody
December 2, 2010Research and Development Cancer, T cell, Torelx, monoclonal antibody
US biopharma company Tolerx is to work with a non-profit cancer research fund to develop its first in class antibody …
Latest content
Five Facts about cardiovascular disease
